1.
Tasso M, Bertolini N, Mostacciuolo E, Passavanti S, Luppino J, Del Puente A, Peluso R, Santelli F, Scarpa R, Costa L, Caso F. Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy. Reumatismo [Internet]. 2022 Dec. 29 [cited 2024 Jul. 23];74(3). Available from: https://www.reumatismo.org/reuma/article/view/1511